Gene: NHS

4810
CTRCT40|CXN|SCML1
NHS actin remodeling regulator
protein-coding
Xp22.2-p22.13
Ensembl:ENSG00000188158 MIM:300457 Vega:OTTHUMG00000022799 UniprotKB:Q6T4R5
NG_011553.2
PubMed
CD|OD|ND|AD
48   
NA (AD)  NA (ND)   (Frontal_Cortex)
NA (AD)  NA (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
RASSF80.719
TGFB20.708
SPPL2A0.701
ITPR20.695
SCML10.694
SLC31A10.68
ARHGAP420.679
BEND70.678
TMEM185B0.676
FSTL10.675

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
S1PR5-0.402
FAM178B-0.396
SLC5A11-0.379
FXYD4-0.373
GJC2-0.373
BTBD16-0.371
ARHGAP22-0.37
FIBCD1-0.363
E2F1-0.358
FCHO1-0.354

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0512461-methylanthracene[1-methylanthracene co-treated with fluoranthene] results in increased expression of NHS mRNA28329830
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of NHS mRNA29067470
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of NHS gene27153756
D017638Asbestos, Crocidolite"Asbestos, Crocidolite results in increased expression of NHS mRNA"18687144
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of NHS mRNA26001963
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased mutagenesis of NHS gene25435355
D004958EstradiolEGF protein inhibits the reaction [Estradiol results in decreased expression of NHS mRNA]24758408
D004958EstradiolEstradiol results in decreased expression of NHS mRNA24758408
C006780bisphenol Abisphenol A results in decreased methylation of NHS promoter27312807
C006780bisphenol Abisphenol A results in decreased expression of NHS mRNA25181051
C018475butyraldehydebutyraldehyde results in increased expression of NHS mRNA26079696
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in decreased expression of NHS mRNA26272509
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NHS gene20938992
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of NHS mRNA27392435
D002945CisplatinCisplatin results in decreased expression of NHS mRNA19561079|2739243
D004041Dietary FatsDietary Fats results in decreased expression of NHS mRNA25016146
D002117CalcitriolCalcitriol results in increased expression of NHS mRNA16002434
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in increased expression of NHS mRNA23649840
C007738fluoranthene[1-methylanthracene co-treated with fluoranthene] results in increased expression of NHS mRNA28329830
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NHS gene20938992
D004397FonofosFonofos results in increased methylation of NHS promoter22847954
D005557FormaldehydeFormaldehyde results in decreased expression of NHS mRNA20655997
D005557FormaldehydeFormaldehyde results in increased expression of NHS mRNA23649840
D006830Hydralazine[Hydralazine co-treated with Valproic Acid] results in increased expression of NHS mRNA17183730
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of NHS mRNA27392435
C544151jinfukangjinfukang results in decreased expression of NHS mRNA27392435
D008558MelphalanMelphalan results in decreased expression of NHS mRNA22363485
C042720mercuric bromidemercuric bromide results in decreased expression of NHS mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA"27188386
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NHS gene20938992
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of NHS mRNA28001369
D010100OxygenOxygen deficiency results in increased expression of NHS mRNA26516004
D010278ParathionParathion results in increased methylation of NHS promoter22847954
C046012pentanalpentanal results in increased expression of NHS mRNA26079696
D010575PesticidesPesticides results in decreased expression of NHS mRNA27406225
C012568terbufosterbufos results in increased methylation of NHS promoter22847954
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of NHS mRNA22574217
D014212TretinoinTretinoin results in decreased expression of NHS mRNA23724009
C012589trichostatin Atrichostatin A results in increased expression of NHS mRNA24935251
D014635Valproic Acid[Hydralazine co-treated with Valproic Acid] results in increased expression of NHS mRNA17183730
D014635Valproic AcidValproic Acid affects the expression of NHS mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of NHS mRNA24935251
D019287Zinc SulfateZinc Sulfate results in decreased expression of NHS mRNA27215404
C088658zoledronic acidzoledronic acid results in decreased expression of NHS mRNA24714768

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO:0002088lens development in camera-type eye-IBA21873635  
GO:0030154cell differentiation-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0005794Golgi apparatus-IDA-  
GO:0005923bicellular tight junction-IEA-  
GO:0005925focal adhesion-IEA-  
GO:0016324apical plasma membrane-IEA-  
GO:0016604nuclear body-IDA-  
GO:0030027lamellipodium-IEA-  
GO:0030054cell junction-IDA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
15924351Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study. (2005 Sep)Tranah GJMol Carcinog
26388349Is grand-parental smoking associated with adolescent obesity? A three-generational study. (2016 Mar)Dougan MMInt J Obes (Lond)
16544653Clean break. (2006 Mar 8-14)Davis CNurs Stand
28497755Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial. (2017 Jun)Lindsay JOLancet Gastroenterol Hepatol
28060453Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review. (2017 Jun)Berg MLAddiction
28255437Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit. (2017 Feb)Gee SHTher Adv Psychopharmacol
19248103Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. (2009 Mar)Karlson EWArthritis Rheum
18462498Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. (2008)Costenbader KHArthritis Res Ther
23495093Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis. (2013 Jul)Karlson EWArthritis Care Res (Hoboken)
25872852Chronic obstructive pulmonary disease part 1: smoking cessation. (2015 Apr 15)Jones DNurs Stand
21611123Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. (2011)Chang CKPLoS One
16257992Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study. (2005 Nov 12)Campbell SMBMJ
18378981Specialised alcohol treatment services are a luxury the NHS cannot afford. (2008 Apr)Luty JBr J Psychiatry
24831822What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. (2014 May)Leaviss JHealth Technol Assess
14988221Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. (2004 Jul)Tranah GJCarcinogenesis
20441712Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. (2010 Apr)Black CHealth Technol Assess
22961230The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. (2013 Oct)Guerriero CEur J Health Econ
27406646Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study. (2016 Jul 12)Dondo TBBMJ Open
26932138Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource. (2016 Mar 1)Perera GBMJ Open
20185811Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes. (2010 May)Hatoum IJDiabetes
10168390Implementation of non-smoking policies in hospitals--Tom Hurst Memorial Lecture. (1996)Ashcroft SWorld Hosp Health Serv
19247474Genome-wide and candidate gene association study of cigarette smoking behaviors. (2009)Caporaso NPLoS One
29247083Study protocol for a randomised controlled trial of Allen Carr's Easyway programme versus Lambeth and Southwark NHS for smoking cessation. (2017 Dec 14)Wood KVBMJ Open
27459457Epidemiological Assessments of Skin Outcomes in the Nurses' Health Studies. (2016 Sep)Li WQAm J Public Health
26370095Are financial incentives cost-effective to support smoking cessation during pregnancy? (2016 Feb)Boyd KAAddiction
17551456Caring for patients with COPD and their families in the community. (2007 May)McHugh GBr J Community Nurs
27664209Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage. (2016 Dec)Jayasena CNHum Reprod
14670879Incidence of cancer among UK Gulf war veterans: cohort study. (2003 Dec 13)Macfarlane GJBMJ
16901700The pathophysiology of emphysema: considerations for critical care nursing practice. (2006 Dec)Mattison SIntensive Crit Care Nurs
25294559Particulate matter and risk of Parkinson disease in a large prospective study of women. (2014 Oct 7)Palacios NEnviron Health
29102992Association of psychological distress, quality of life and costs with carpal tunnel syndrome severity: a cross-sectional analysis of the PALMS cohort. (2017 Nov 3)Jerosch-Herold CBMJ Open
14612848Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. (2003 Sep)Elhadd TAInt Angiol
19149829Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. (2009 Feb)Boyd KAAddiction
24847019In utero exposure to cigarette smoke dysregulates human fetal ovarian developmental signalling. (2014 Jul)Fowler PAHum Reprod
24685909Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. (2015 Aug)Sparks JAAnn Rheum Dis
29669708Evaluation of Two Mobile Health Apps in the Context of Smoking Cessation: Qualitative Study of Cognitive Behavioral Therapy (CBT) Versus Non-CBT-Based Digital Solutions. (2018 Apr 18)Tudor-Sfetea CJMIR Mhealth Uhealth
24293491[Volumes of services supplied by Italian Stop-Smoking Services and their characteristics predictive of abstinence]. (2013 Jul-Oct)Gorini GEpidemiol Prev
21062464Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. (2010 Nov 9)Marteau TMBMC Public Health
20051749Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers. (2010 Jan)Abhishek AJ Clin Rheumatol
18063597Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. (2008 Jan)Jensen MKEur Heart J
17004407Best practice in smoking cessation services for pregnant women: results of a survey of three services reporting the highest national returns, and three beacon services. (2006 Sep)Lee MJ R Soc Promot Health
27703782Ketamine: stimulating antidepressant treatment? (2016 May)Malhi GSBJPsych Open
25403204Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. (2015 Jan 1)Yuan CJ Clin Oncol
26098791Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis. (2015 Oct)Kim KArthritis Rheumatol
24474868Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy. (2012)Colombo GLSubst Abuse Rehabil
27417619StopApp: Using the Behaviour Change Wheel to Develop an App to Increase Uptake and Attendance at NHS Stop Smoking Services. (2016 Jun 8)Fulton EAHealthcare (Basel)
25409898An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service. (2015 Feb)Wright DInt J Pharm Pract
19194882Genetic determinants of hair color and Parkinson's disease risk. (2009 Jan)Gao XAnn Neurol